Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2026-02-22 @ 3:55 PM
Study NCT ID:
NCT01066403
Status:
COMPLETED
Last Update Posted:
2010-02-10
First Post:
2010-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
Sponsor:
Heidelberg University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Schizophrenia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | schizophrenia | View |
| None | cognitive deficits | View |
| None | dopamine | View |
| None | dopamine agonists | View |
| None | prefrontal cortex | View |
| None | D1 specific modulation | View |
| None | pergolide | View |
| None | executive control | View |
| None | working memory | View |
| None | Influence of pergolide on cognition in Schizophrenia | View |
| None | D1-specific modulation of prefrontal functions | View |
| None | Influence of pergolide on psychopathology and depression | View |
| None | Influence of pergolide on extrapyramidal symptoms | View |